Nimodipine and Nervous System Function

  • J. Traber
  • F. J. van der Staay
  • J. de Vry
Conference paper


Nimodipine is a Ca2+ antagonist of the 1,4-dihydropyridine type that specifically blocks the L-type Ca2+ channel by reducing its opening probability. Binding sites for nimodipine are distinctly located in the central nervous system (CNS), especially in the hippocampal formation and the cortex. These brain structures play an important role in the regulation of cognitive processes. Nimodipine acts not only on neurons but also on glial cells (Hertz et al. 1989). This finding may be highly relevant for nimodipine’s action, given the fact that 50% of the cells in the CNS consist of glial cells which support and modulate the function of neurones in the CNS. Finally, there are binding sites for nimodipine on CNS blood vessels which thus provide another target for the drug.


Middle Cerebral Artery Occlusion Force Swimming Test Nerve Conductance Velocity Nervous System Function Acquisition Session 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bielenberg GW, Beck T (1991) The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res 552:338–342PubMedCrossRefGoogle Scholar
  2. Czyrak A, Mogilnicka E, Siwanowicz J, Maj J (1990) Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav 35:557–560PubMedCrossRefGoogle Scholar
  3. de Jong GI, de Weerd H, Schuurman T, Traber J, Luiten PGM (1990) Microvascular changes in aged rat forebrain. Effects of chronic nimodipine treatment. Neurobiol Aging 11:381–389Google Scholar
  4. de Jong GI, Jansen ASP, Horvath E, Gispen WH, Luiten PGM (1991) Nimodipine effects on cerebral micro vessels and sciatic nerve in aging rats. Neurobiol Aging 13:73–81CrossRefGoogle Scholar
  5. de Jong GI, Nyakas C, Schuurman T, Luiten PGM (1992) Aging-related alterations in behavioral activation and cerebrovascular integrity in rats are dose-dependently influenced by nimodipine. Neurosci Res Commun 12:1–8Google Scholar
  6. Deyo RA, Straube KT, Disterhoft JH (1989) Nimodipine facilitates associative learning in aging rabbits. Science 243:809–811PubMedCrossRefGoogle Scholar
  7. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364–367PubMedCrossRefGoogle Scholar
  8. Engel JA, Fahlke C, Hulthe P, Hard E, Johannessen K, Snape B, Svensson L (1988) Biochemical and behavioral evidence for an interaction between ethanol and calcium channel antagonists. J Neural Transm 74:181–193PubMedCrossRefGoogle Scholar
  9. Finger S, Green L, Tarnoff ME, Mortman KD, Andersen A (1990) Nimodipine enhances new learning after hippocampal damage. Exp Neurol 109:279–285PubMedCrossRefGoogle Scholar
  10. Gispen WH, Schuurman T, Traber J (1988) Nimodipine and neural plasticity in the peripheral nervous system of adult and aged rats. In: Morad M, Nayler W, Kazda S, Schramm M (eds) The calcium channel: structure, function and implications. Springer, Berlin Heidelberg New York, pp 491–502CrossRefGoogle Scholar
  11. Harper AM, Craigen L, Kazda S (1981) Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate. J Cereb Blood Flow Metab 1:349–356PubMedCrossRefGoogle Scholar
  12. Hertz L, Bender AS, Woodbury DM, White HS (1989) Potassium-stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine. J Neurosci Res 22:209–215PubMedCrossRefGoogle Scholar
  13. Kappelle AC, Bravenboer B, Traber J, Erkelens DW, Gispen WH (1992) The Ca2+ antagonist nimodipine counteracts the onset of an experimental neuropathy in streptozotocin induced, diabetic rats. Neurosci Res Commun 10:95–104Google Scholar
  14. Kappelle AC, Bravenboer B, van Buren T, Traber J, Erkelens DW, Gispen WH (1993) Amelioration by the Ca2+ antagonist nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br J Pharmacol 108:780–785PubMedGoogle Scholar
  15. Kazda S, Garthoff B, Krause HP, SchloBmann K (1982) Cerebrovascular effects of the calcium antagonist dihydropyridine derivative nimodipine in animal experiments. Arzneimittelforschung 32:331–338PubMedGoogle Scholar
  16. Khatchaturian ZS (1989) The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging 1:17–34Google Scholar
  17. Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W (1992) Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 41:497–500PubMedCrossRefGoogle Scholar
  18. Porsolt RD, LePichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatment. Nature 266:730–732PubMedCrossRefGoogle Scholar
  19. Porsolt RD, Anton G, Blavet M, Jalfre M (1978) Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391PubMedCrossRefGoogle Scholar
  20. Pucilowski O, Rezvani AH, Janowsky DS (1992) Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438. Psychopharmacology 107:447–452PubMedCrossRefGoogle Scholar
  21. Rezvani AH, Janowsky DS (1990) Decreased alcohol consumption by verapamil in alcohol preferring rats. Prog Neuropsychopharmacol Biol Psychiatry 14:623–631PubMedCrossRefGoogle Scholar
  22. Ritz M, George FR, Meisch RA (1989) Ethanol self-administration in ALKO rats: I. Effects of selection and concentration. Alcohol 6:227–233Google Scholar
  23. Sandin M, Jasmin S, LeVere TE (1990) Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine. Neurobiol Aging 11:573– 575PubMedCrossRefGoogle Scholar
  24. Schuurman T, Traber J (1989a) Old rats as an animal model for senile dementia: behavioral effects of nimodipine. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York, pp 295-307Google Scholar
  25. Schuurman T, Traber J (1989b) Effects of nimodipine on behavior of old rats. In: Traber J, Gispen WH (eds) Nimodipine and central nervous system function: new vistas. Schattauer, Stuttgart, pp 195–208Google Scholar
  26. Schuurman T, Klein H, Beneke M, Traber J (1987) Nimodipine and motor deficits in aged rats. Neurosci Res Commun 1:9–15Google Scholar
  27. Uematsu D, Greenberg JH, Hickey WF, Reivich M (1989) Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20:1531-1537 van der Zee CEEM, Schuurman T, Traber J, Gispen WH (1987) Oral administration of nimodipine accelerates functional recovery following peripheral nerve damage in the rat. Neurosci Lett 83:143–148Google Scholar
  28. van der Zee CEEM, Schuurman T, Gerritsen van der Hoop R, Traber J, Gispen WH (1990) Beneficial effect of nimodipine on peripheral nerve function in aged rats. Neurobiol Aging 11:451–456PubMedCrossRefGoogle Scholar
  29. Whittington MA, Dolin SJ, Patch TL, Siarey RJ, Butterworth AR, Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptation to, chronic ethanol treatment. Br J Pharmacol 103:1669–1676PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • J. Traber
    • 1
  • F. J. van der Staay
    • 1
  • J. de Vry
    • 1
  1. 1.Bayer-Tropon Institute for NeurobiologyTroponwerkeCologneGermany

Personalised recommendations